Today

Agents

Chat

Arena

Discover

More

App

Regeneron Pharmaceuticals: RBC raises target price to $810 from $737

REGN•2026-10-08

RBC raised its target price for Regeneron Pharmaceuticals to $810 from $737.

Related News

A

Axsome Therapeutics, Inc.: RBC cuts target price to $295 from $297

AXSM•2026-10-08

Levi Strauss & Co: BofA Global Research cuts price objective to $25 from $27

LEVI•2026-10-08

Frequency Electronics holds annual shareholder meeting

FEIM•2026-10-08

Haemonetics says CSL Plasma expects U.S. rollout of its devices at all centers by end-2027

HAE•2026-10-08

51Talk CEO Jack Jiajia Huang reports US$32.37 million China Online Education Group share purchase

COE•2026-10-08

Regeneron Pharmaceuticals: RBC raises target price to $810 from $737 - REGN News | Rallies